CLOSE ×
    Go to Blog Biotage joins the Swedish GeneNova Collaboration for Gene Therapy Drugs

    Biotage joins the Swedish GeneNova Collaboration for Gene Therapy Drugs

    Biotage

    Funded by academia, Vinnova and industry, a five-year multi-disciplinary collaboration has been launched to improve efficiency in production methods for adeno-associated virus (AAV) based gene therapies. Biotage is contributing with technology and expertise in plasmid DNA and AAV purification, as well as by funding a dedicated PhD student within the project. “We are thrilled to join the GeneNova project to develop transformative improvements of the drug development and production processes for gene therapies.” says Tomas Blomquist, President and CEO of Biotage.

    Read the press release here.

    Subscribe today!

    Subscribe now to be the first to get notified when our in-house experts have published a new blog.

    Sign Up

    Sign Up